Arrhythmias & electrophysiology

Long-term performance of subcutaneous implantable defibrillators in athletes: A multicenter, real-world analysis of sport activities from the iSUSI registry

Heart RhythmPublished Registry-based cohort study

Authors' conclusion

Sports practice was not associated with an increased risk of complications or inappropriate shocks, although athletes are exposed to a higher risk of S-ICD infections in the early postoperative period.

Study context

Population
Patients with subcutaneous ICD in the iSUSI registry152 (10.2%) athletes
Participants
1,493 patients
Exposure
Athletes vs nonathletes with subcutaneous-implantable cardioverter defibrillator (S-ICD)
  • Athletesn = 152
Outcome
Overall device-related complications
Follow-up
Median 25.5 (12.0-41.2) months
Methodological detailsmulticentre, real-world
  • Multicentre
  • Real-world

Main finding

As reported in the abstract

Overall device-related complications (yearly rate)
  • No differences in overall device-related complications
  • Athletes vs Nonathletes: P = 0.448

Observational data: associations, not effects.

Secondary outcomes

Appropriate shocks (yearly rate) · unadjusted

P = 0.028

OutcomeaHR (CI)P value
Appropriate shocks (yearly rate)Adjusted for confounders; lost significance1.440 (0.909–2.281)P = 0.120

Appropriate shocks during exercise

P < 0.001

Safety

OutcomeP value
Inappropriate shocks (yearly rate)Yearly rate: 5.3% vs 3.7%; no differenceP = 0.111
Myopotential oversensing4.0% vs 1.3%; more common in athletesP = 0.011
Lead infections3.3% vs 0.9%; more common in athletes · clustering in the early postimplantation periodP = 0.008

Original publication

Long-term performance of subcutaneous implantable defibrillators in athletes: A multicenter, real-world analysis of sport activities from the iSUSI registry. Heart Rhythm. Published 20 September 2024. doi:10.1016/j.hrthm.2024.09.039

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.